Corrigendum to: A Multicenter 12-Month Retrospective Evaluation of Canaloplasty and Trabeculotomy in Patients with Open-Angle Glaucoma: The ROMEO 2 Study (Clin Ophthalmol. 2022, 16, 3043–3052)

Abstract

On page 3043, the second sentence of the Introduction, “The study was the basis of the FDA approved OSS indication to “reduce IOP in adult patients with open-angle glaucoma”.” should read “The study was the basis of the FDA cleared OSS indication to “reduce IOP in adult patients with primary open-angle glaucoma”.” The authors apologize for this error and advise it does not affect the results of the paper.